Clover Health Investments, Corp. (NASDAQ:CLOV - Free Report) - Equities researchers at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Clover Health Investments in a note issued to investors on Tuesday, March 19th. Leerink Partnrs analyst W. Mayo anticipates that the company will earn ($0.06) per share for the quarter. The consensus estimate for Clover Health Investments' current full-year earnings is ($0.10) per share. Leerink Partnrs also issued estimates for Clover Health Investments' Q2 2025 earnings at ($0.02) EPS, Q3 2025 earnings at ($0.02) EPS, Q4 2025 earnings at ($0.06) EPS and FY2028 earnings at ($0.09) EPS.
Clover Health Investments Trading Down 2.0 %
Shares of NASDAQ:CLOV traded down $0.02 on Thursday, hitting $0.86. The company had a trading volume of 8,761,325 shares, compared to its average volume of 9,613,690. The business has a 50 day moving average of $0.92 and a 200 day moving average of $0.99. Clover Health Investments has a 52-week low of $0.71 and a 52-week high of $1.63. The company has a market cap of $421.32 million, a PE ratio of -1.95 and a beta of 1.85.
Insider Buying and Selling
In other Clover Health Investments news, Director Anna U. Loengard bought 137,000 shares of Clover Health Investments stock in a transaction that occurred on Thursday, March 14th. The shares were purchased at an average cost of $0.73 per share, for a total transaction of $100,010.00. Following the completion of the transaction, the director now owns 538,841 shares of the company's stock, valued at approximately $393,353.93. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 21.82% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Several hedge funds have recently made changes to their positions in the company. JPMorgan Chase & Co. raised its stake in Clover Health Investments by 10.2% during the 1st quarter. JPMorgan Chase & Co. now owns 77,719 shares of the company's stock valued at $276,000 after acquiring an additional 7,199 shares in the last quarter. Cambridge Investment Research Advisors Inc. raised its stake in Clover Health Investments by 15.5% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 57,507 shares of the company's stock valued at $204,000 after acquiring an additional 7,730 shares in the last quarter. Oppenheimer & Co. Inc. bought a new stake in Clover Health Investments during the 1st quarter valued at $74,000. BlackRock Inc. raised its stake in Clover Health Investments by 6.2% during the 1st quarter. BlackRock Inc. now owns 5,681,089 shares of the company's stock valued at $20,168,000 after acquiring an additional 329,673 shares in the last quarter. Finally, Vanguard Group Inc. raised its stake in Clover Health Investments by 0.8% during the 1st quarter. Vanguard Group Inc. now owns 26,087,528 shares of the company's stock valued at $92,611,000 after acquiring an additional 200,177 shares in the last quarter. Institutional investors and hedge funds own 19.95% of the company's stock.
Clover Health Investments Company Profile
(
Get Free Report)
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses.
Recommended Stories
Before you consider Clover Health Investments, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.
While Clover Health Investments currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
